Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Biol Blood Marrow Transplant. 2014 Nov 1;21(2):335–341. doi: 10.1016/j.bbmt.2014.10.023

Figure 1.

Figure 1

(A). Progression-free survival (PFS) of patients who achieved suboptimal response (<PR) vs. an overall response (CR/PR) to 1st line induction chemotherapy

(B). Overall survival (OS) of patients who achieved suboptimal response (<PR) vs. an overall response (CR/PR) to 1st line induction chemotherapy